Alex Pu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alex Pu has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Diljon Chahal
University of Maryland Baltimore School of Medicine Baltimore Maryland USA
2 shared publicationsHaytham Allaham
University of Maryland Baltimore School of Medicine Baltimore Maryland USA
2 shared publications- Mohit N. Gilotra
Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD, USA
2 shared publications Rahul V. Annabathula
Division of Cardiovascular Medicine University of Maryland School of Medicine Baltimore Maryland USA
2 shared publications- Alexandra E. Thomson
Division of Spine Surgery, Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD 21201, USA
1 shared publication - Amil Sahai
Division of Spine Surgery, Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD 21021, USA
1 shared publication
Latest Publications
- 23 April 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 108 (1) , 189-196
Acute Hypoxemic Respiratory Failure Following Mitral Transcatheter Edge‐to‐Edge Repair: The Role of Aortic Stenosis
Background: The coexistence of severe mitral regurgitation (MR) and mild‐to‐moderate aortic stenosis (AS) presents diagnostic and therapeutic challenges. Limited data exists on outcomes following mitral transcatheter edge‐to‐edge repair (M‐TEER) therapy in this patient population. Aims: This study is aimed to evaluate clinical outcomes following M‐TEER in patients with mild‐to‐modearte AS compared with those without aortic stenosis. Methods: A single‐center retrospective study was conducted on 238 patients who underwent M‐TEER therapy between January 2014 and December 2024. Patients with severe AS, cardiogenic shock, and failed or aborted cases were excluded. We compared patients with mild‐to‐moderate AS ( n = 30) to those without AS ( n = 208). Primary outcome: Acute hypoxemic respiratory failure (AHRF) within 24 h (SpO 2 ≤ 90% ≥ 30 min or need for O 2 /NIV/IMV, adjudicated as cardiogenic). Secondary outcomes: Post‐procedural in‐hospital mortality, acute kidney injury, hospital length of stay (LOS), 30‐day rate of heart failure hospitalization (HFH), and 30‐day rate of all‐cause readmission. Multivariable logistic regression was used to identify independent predictors of AHRF, hospital LOS, and 30‐day HFH. Results: Following M‐TEER, the mild‐to‐moderate AS group experienced significantly higher rates of AHRF (16.7% vs. 3.8%, p = 0.0142; adjusted OR 4.38, 95% CI 1.36–14.61, p = 0.014). Within the parsimonious adjusted model, AS remained independently associated with AHRF, whereas the other included covariates were not. There was no significant difference in the 30‐day rate of all‐cause readmission, 30‐day rate of HFH, AKI, LOS, or in‐hospital mortality between groups. Conclusion: In patients undergoing M‐TEER, the presence of mild‐to‐moderate AS is independently associated with an increased risk of early post‐procedural AHRF, without differences in other short‐term clinical outcomes. Given the single‐center retrospective design and the limited number of clinical events, these findings should be considered hypothesis‐generating and warrant validation in larger, prospective, multicenter studies.
- 23 April 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 108 (1) , 189-196
Acute Hypoxemic Respiratory Failure Following Mitral Transcatheter Edge‐to‐Edge Repair: The Role of Aortic Stenosis
Background: The coexistence of severe mitral regurgitation (MR) and mild‐to‐moderate aortic stenosis (AS) presents diagnostic and therapeutic challenges. Limited data exists on outcomes following mitral transcatheter edge‐to‐edge repair (M‐TEER) therapy in this patient population. Aims: This study is aimed to evaluate clinical outcomes following M‐TEER in patients with mild‐to‐modearte AS compared with those without aortic stenosis. Methods: A single‐center retrospective study was conducted on 238 patients who underwent M‐TEER therapy between January 2014 and December 2024. Patients with severe AS, cardiogenic shock, and failed or aborted cases were excluded. We compared patients with mild‐to‐moderate AS ( n = 30) to those without AS ( n = 208). Primary outcome: Acute hypoxemic respiratory failure (AHRF) within 24 h (SpO 2 ≤ 90% ≥ 30 min or need for O 2 /NIV/IMV, adjudicated as cardiogenic). Secondary outcomes: Post‐procedural in‐hospital mortality, acute kidney injury, hospital length of stay (LOS), 30‐day rate of heart failure hospitalization (HFH), and 30‐day rate of all‐cause readmission. Multivariable logistic regression was used to identify independent predictors of AHRF, hospital LOS, and 30‐day HFH. Results: Following M‐TEER, the mild‐to‐moderate AS group experienced significantly higher rates of AHRF (16.7% vs. 3.8%, p = 0.0142; adjusted OR 4.38, 95% CI 1.36–14.61, p = 0.014). Within the parsimonious adjusted model, AS remained independently associated with AHRF, whereas the other included covariates were not. There was no significant difference in the 30‐day rate of all‐cause readmission, 30‐day rate of HFH, AKI, LOS, or in‐hospital mortality between groups. Conclusion: In patients undergoing M‐TEER, the presence of mild‐to‐moderate AS is independently associated with an increased risk of early post‐procedural AHRF, without differences in other short‐term clinical outcomes. Given the single‐center retrospective design and the limited number of clinical events, these findings should be considered hypothesis‐generating and warrant validation in larger, prospective, multicenter studies.
- Open Access
- 7 September 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (5) , 3011-3017
In‐Hospital Outcomes of Simultaneous and Staged Transcatheter Aortic Valve Replacement and Endovascular Aneurysm Repair
Introduction: Patients with aortic aneurysms are at elevated risk of rupture, dissection and death during and after transcatheter aortic valve repair (TAVR), often requiring consideration for endovascular aneurysm repair (EVAR) at the time of TAVR. However, data comparing outcomes of simultaneous versus staged TAVR‐EVAR are limited. Methods: Using the National Inpatient Sample between the years 2018 and 2021, we compared in‐hospital outcomes of simultaneous and staged TAVR‐EVAR. Patients who underwent both TAVR and EVAR during hospital admission were identified with International Classification of Diseases 10th Revision procedure codes. Patients were stratified by simultaneous (defined as same day) versus staged (defined as different day) procedures. Propensity score matching was done in a 2:1 fashion to account for differences in baseline characteristics, and mixed effects multivariate regression models were used to assess differences in in‐hospital mortality, cost of hospitalization, length of stay, and other procedural complications. Results: A total of 270 patients underwent simultaneous TAVR‐EVAR, while a total of 70 underwent staged TAVR‐EVAR. After propensity score matching, 98 patients undergoing simultaneous TAVR‐EVAR were matched to 49 patients undergoing staged TAVR‐EVAR. No significant differences in baseline characteristics were observed after matching. In‐hospital mortality between the matched groups was not significantly different (OR 0.67, p = 0.409), however the simultaneous group was associated with shorter length of stay (3 [2.0−11.75] days vs. 14 [13.0−17.0] days, p < 0.001) and less total hospital costs ($77,691 [$65,153−$103,854] vs. $148,617 [$128,339−$217,988]; p < 0.001). The matched simultaneous group was also associated with lower incidence of acute kidney injury (25.5% vs. 65.3%; OR 0.11, p < 0.001), blood transfusions (20.4% vs. 40.8%; OR 0.37, p = 0.01), and access site complications (< 10.2% vs. 49.0%; OR 0.00, p < 0.001). Conclusion: Simultaneous TAVR‐EVAR is associated with fewer adverse complications and lower cost of hospitalization without increased in‐hospital mortality, suggesting it is more cost effective than staged TAVR‐EVAR during the same hospital admission.
- 7 September 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (5) , 3011-3017
Open AccessIn‐Hospital Outcomes of Simultaneous and Staged Transcatheter Aortic Valve Replacement and Endovascular Aneurysm Repair
Introduction: Patients with aortic aneurysms are at elevated risk of rupture, dissection and death during and after transcatheter aortic valve repair (TAVR), often requiring consideration for endovascular aneurysm repair (EVAR) at the time of TAVR. However, data comparing outcomes of simultaneous versus staged TAVR‐EVAR are limited. Methods: Using the National Inpatient Sample between the years 2018 and 2021, we compared in‐hospital outcomes of simultaneous and staged TAVR‐EVAR. Patients who underwent both TAVR and EVAR during hospital admission were identified with International Classification of Diseases 10th Revision procedure codes. Patients were stratified by simultaneous (defined as same day) versus staged (defined as different day) procedures. Propensity score matching was done in a 2:1 fashion to account for differences in baseline characteristics, and mixed effects multivariate regression models were used to assess differences in in‐hospital mortality, cost of hospitalization, length of stay, and other procedural complications. Results: A total of 270 patients underwent simultaneous TAVR‐EVAR, while a total of 70 underwent staged TAVR‐EVAR. After propensity score matching, 98 patients undergoing simultaneous TAVR‐EVAR were matched to 49 patients undergoing staged TAVR‐EVAR. No significant differences in baseline characteristics were observed after matching. In‐hospital mortality between the matched groups was not significantly different (OR 0.67, p = 0.409), however the simultaneous group was associated with shorter length of stay (3 [2.0−11.75] days vs. 14 [13.0−17.0] days, p < 0.001) and less total hospital costs ($77,691 [$65,153−$103,854] vs. $148,617 [$128,339−$217,988]; p < 0.001). The matched simultaneous group was also associated with lower incidence of acute kidney injury (25.5% vs. 65.3%; OR 0.11, p < 0.001), blood transfusions (20.4% vs. 40.8%; OR 0.37, p = 0.01), and access site complications (< 10.2% vs. 49.0%; OR 0.00, p < 0.001). Conclusion: Simultaneous TAVR‐EVAR is associated with fewer adverse complications and lower cost of hospitalization without increased in‐hospital mortality, suggesting it is more cost effective than staged TAVR‐EVAR during the same hospital admission.
- Open Access
- 1 January 2025
- Published by Texas Heart Institute Journal in Texas Heart Institute Journal
- Vol. 52 (1) , e258577
Coronary-Cameral Fistula Following Myectomy in Hypertrophic Obstructive Cardiomyopathy
- 1 January 2025
- Published by Texas Heart Institute Journal in Texas Heart Institute Journal
- Vol. 52 (1) , e258577
Open AccessCoronary-Cameral Fistula Following Myectomy in Hypertrophic Obstructive Cardiomyopathy
- 25 April 2024
- Published by Wiley in Liver International
- Vol. 44 (8) , 2011-2037
The impact of macro‐ and micro‐steatosis on the outcomes of patients who undergo liver transplant: Analysis of the UNOS‐STAR database
Background and Aims: The presence of steatosis in a donor liver and its relation to post‐transplantation outcomes are not well defined. This study evaluates the effect of the presence and severity of micro‐ and macro‐steatosis of a donor graft on post‐transplantation outcomes. Methods: The UNOS‐STAR registry (2005–2019) was used to select patients who received a liver transplant graft with hepatic steatosis. The study cohort was stratified by the presence of macro‐ or micro‐vesicular steatosis, and further stratified by histologic grade of steatosis. The primary endpoints of all‐cause mortality and graft failure were compared using sequential Cox regression analysis. Analysis of specific causes of mortality was further performed. Results: There were 9184 with no macro‐steatosis (control), 150 with grade 3 macro‐steatosis, 822 with grade 2 macro‐steatosis and 12 585 with grade 1 macro‐steatosis. There were 10 320 without micro‐steatosis (control), 478 with grade 3 micro‐steatosis, 1539 with grade 2 micro‐steatosis and 10 404 with grade 1 micro‐steatosis. There was no significant difference in all‐cause mortality or graft failure among recipients who received a donor organ with any evidence of macro‐ or micro‐steatosis, compared to those receiving non‐steatotic grafts. There was increased mortality due to cardiac arrest among recipients of a grade 2 macro‐steatosis donor organ. Conclusion: This study shows no significant difference in all‐cause mortality or graft failure among recipients who received a donor liver with any degree of micro‐ or macro‐steatosis. Further analysis identified increased mortality due to specific aetiologies among recipients receiving donor organs with varying grades of macro‐ and micro‐steatosis.
- 25 April 2024
- Published by Wiley in Liver International
- Vol. 44 (8) , 2011-2037
The impact of macro‐ and micro‐steatosis on the outcomes of patients who undergo liver transplant: Analysis of the UNOS‐STAR database
Background and Aims: The presence of steatosis in a donor liver and its relation to post‐transplantation outcomes are not well defined. This study evaluates the effect of the presence and severity of micro‐ and macro‐steatosis of a donor graft on post‐transplantation outcomes. Methods: The UNOS‐STAR registry (2005–2019) was used to select patients who received a liver transplant graft with hepatic steatosis. The study cohort was stratified by the presence of macro‐ or micro‐vesicular steatosis, and further stratified by histologic grade of steatosis. The primary endpoints of all‐cause mortality and graft failure were compared using sequential Cox regression analysis. Analysis of specific causes of mortality was further performed. Results: There were 9184 with no macro‐steatosis (control), 150 with grade 3 macro‐steatosis, 822 with grade 2 macro‐steatosis and 12 585 with grade 1 macro‐steatosis. There were 10 320 without micro‐steatosis (control), 478 with grade 3 micro‐steatosis, 1539 with grade 2 micro‐steatosis and 10 404 with grade 1 micro‐steatosis. There was no significant difference in all‐cause mortality or graft failure among recipients who received a donor organ with any evidence of macro‐ or micro‐steatosis, compared to those receiving non‐steatotic grafts. There was increased mortality due to cardiac arrest among recipients of a grade 2 macro‐steatosis donor organ. Conclusion: This study shows no significant difference in all‐cause mortality or graft failure among recipients who received a donor liver with any degree of micro‐ or macro‐steatosis. Further analysis identified increased mortality due to specific aetiologies among recipients receiving donor organs with varying grades of macro‐ and micro‐steatosis.
- 25 October 2023
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 482 (1) , 9-19
Better Mobility Is Associated With Higher Incomes and Longer Working Years Among Older Adults
Background: Robust physical mobility is the key to healthy independent aging. Although the association between socioeconomic status and health is well documented, it is unclear whether there is a relationship between mobility and income, because income data are not readily available. Questions/purposes: (1) Do individuals with better mobility have higher incomes? (2) Does maintaining mobility over time allow individuals to keep working? (3) Is exercise associated with higher mobility over time? Methods: We obtained longitudinal income and health data from the nationally representative Health and Retirement Study. Three cohorts were used. First, we studied the relationship between household income and mobility (on a 6-point index of walking impairment) in 19,430 adults who were assessed in 2016 (representing 93% of the 20,805-person total cohort). We measured the association of mobility and household income in a multivariate linear regression analysis of age, gender, health conditions, and education. We then identified a second group of 1094 individuals with unrestricted mobility in the year 2000 and compared differences in income and working rates between those who maintained mobility and those who lost mobility after 10 years. Finally, we identified a third group of 7063 individuals who were 60 to 80 years old in 2012, divided the group by how often they engaged in exercise, and observed differences in mobility after 4 years. Results: After adjusting for covariates, a drop of one level of mobility was associated with a USD 3410 reduction in annual household income (95% CI USD 2890 to USD 3920; p < 0.001). After 10 years, individuals who maintained their mobility had incomes that were USD 6500 higher than that of individuals who were not working (95% CI USD 2300 to USD 10,300; p < 0.001) and were more likely to be working (40% versus 34.5%; p < 0.001). Exercising at least once per week was associated with better mobility 4 years later (mobility score 4.46 ± 0.08 versus 3.66 ± 0.08; p < 0.001). Conclusion: Better mobility was associated with more than USD 3000 in annual income. Regular exercise and other interventions that improve mobility may have meaningful returns on investment. Clinical Relevance: Because greater mobility is strongly associated with higher income, orthopaedic interventions may be undervalued.
- 25 October 2023
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 482 (1) , 9-19
Better Mobility Is Associated With Higher Incomes and Longer Working Years Among Older Adults
Background: Robust physical mobility is the key to healthy independent aging. Although the association between socioeconomic status and health is well documented, it is unclear whether there is a relationship between mobility and income, because income data are not readily available. Questions/purposes: (1) Do individuals with better mobility have higher incomes? (2) Does maintaining mobility over time allow individuals to keep working? (3) Is exercise associated with higher mobility over time? Methods: We obtained longitudinal income and health data from the nationally representative Health and Retirement Study. Three cohorts were used. First, we studied the relationship between household income and mobility (on a 6-point index of walking impairment) in 19,430 adults who were assessed in 2016 (representing 93% of the 20,805-person total cohort). We measured the association of mobility and household income in a multivariate linear regression analysis of age, gender, health conditions, and education. We then identified a second group of 1094 individuals with unrestricted mobility in the year 2000 and compared differences in income and working rates between those who maintained mobility and those who lost mobility after 10 years. Finally, we identified a third group of 7063 individuals who were 60 to 80 years old in 2012, divided the group by how often they engaged in exercise, and observed differences in mobility after 4 years. Results: After adjusting for covariates, a drop of one level of mobility was associated with a USD 3410 reduction in annual household income (95% CI USD 2890 to USD 3920; p < 0.001). After 10 years, individuals who maintained their mobility had incomes that were USD 6500 higher than that of individuals who were not working (95% CI USD 2300 to USD 10,300; p < 0.001) and were more likely to be working (40% versus 34.5%; p < 0.001). Exercising at least once per week was associated with better mobility 4 years later (mobility score 4.46 ± 0.08 versus 3.66 ± 0.08; p < 0.001). Conclusion: Better mobility was associated with more than USD 3000 in annual income. Regular exercise and other interventions that improve mobility may have meaningful returns on investment. Clinical Relevance: Because greater mobility is strongly associated with higher income, orthopaedic interventions may be undervalued.
- Open Access
- 14 March 2022
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 40 (12) , 2743-2753
Fibroadipogenic progenitor cell response peaks prior to progressive fatty infiltration after rotator cuff tendon tear
Fibroadipogenic progenitor (FAP) cells are implicated as a major source of fatty infiltration (FI) in murine rotator cuff (RC) injury, but FAP cell response after RC tear in a rabbit model is unknown. This study determined whether changes in FAP cell count after an RC tear predate muscle degeneration in a clinically relevant rabbit model. We hypothesized increases in FAP cell count correlate temporally with RC degeneration. New Zealand white rabbits (n = 26) were evaluated at 1, 2, 4, and 6 weeks after unilateral full‐thickness tenotomy of supraspinatus and infraspinatus tendons. FI area and adipocyte size were histologically analyzed, muscle density was measured by computerized tomography, and quantification of FAP cells was measured by flow cytometry and immunohistochemistry. The percentage of intrafascicular adipocyte area increased over time in supraspinatus muscle samples (p = 0.03), significantly between 1‐ and 6‐week samples (p = 0.04). There were no differences in perifascicular adipocyte area percentages between time points. Peak increase in FAP cell count occurred at 1‐week (p = 0.03), with a decrease in the following weeks. There was a negative correlation between supraspinatus adipocyte area and FAP cell count (p < 0.05). On computed tomography (CT) scan, maximal decrease in muscle density was observed in the 4th to 6th weeks. In summary, FAP cell response occurred early after tenotomy and did not correlate temporally with increases in FI. This suggests that FAP cell response may predate degenerative changes, and early targeting of FAPs before adipocyte maturation could blunt FI after RC tear.
- 14 March 2022
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 40 (12) , 2743-2753
Open AccessFibroadipogenic progenitor cell response peaks prior to progressive fatty infiltration after rotator cuff tendon tear
Fibroadipogenic progenitor (FAP) cells are implicated as a major source of fatty infiltration (FI) in murine rotator cuff (RC) injury, but FAP cell response after RC tear in a rabbit model is unknown. This study determined whether changes in FAP cell count after an RC tear predate muscle degeneration in a clinically relevant rabbit model. We hypothesized increases in FAP cell count correlate temporally with RC degeneration. New Zealand white rabbits (n = 26) were evaluated at 1, 2, 4, and 6 weeks after unilateral full‐thickness tenotomy of supraspinatus and infraspinatus tendons. FI area and adipocyte size were histologically analyzed, muscle density was measured by computerized tomography, and quantification of FAP cells was measured by flow cytometry and immunohistochemistry. The percentage of intrafascicular adipocyte area increased over time in supraspinatus muscle samples (p = 0.03), significantly between 1‐ and 6‐week samples (p = 0.04). There were no differences in perifascicular adipocyte area percentages between time points. Peak increase in FAP cell count occurred at 1‐week (p = 0.03), with a decrease in the following weeks. There was a negative correlation between supraspinatus adipocyte area and FAP cell count (p < 0.05). On computed tomography (CT) scan, maximal decrease in muscle density was observed in the 4th to 6th weeks. In summary, FAP cell response occurred early after tenotomy and did not correlate temporally with increases in FI. This suggests that FAP cell response may predate degenerative changes, and early targeting of FAPs before adipocyte maturation could blunt FI after RC tear.
- 1 October 2021
- Published by Elsevier in World Neurosurgery
- Vol. 154, e649-e655
Dural Tear Does not Increase the Rate of Venous Thromboembolic Disease in Patients Undergoing Elective Lumbar Decompression with Instrumented Fusion
- 1 October 2021
- Published by Elsevier in World Neurosurgery
- Vol. 154, e649-e655
Dural Tear Does not Increase the Rate of Venous Thromboembolic Disease in Patients Undergoing Elective Lumbar Decompression with Instrumented Fusion
- 1 September 2021
- Published by Elsevier in Journal of Orthopaedics
- Vol. 27, 114-121
Radiographic evaluation of osteochondritis dissecans of the humeral capitellum: A systematic review
- 1 September 2021
- Published by Elsevier in Journal of Orthopaedics
- Vol. 27, 114-121
Radiographic evaluation of osteochondritis dissecans of the humeral capitellum: A systematic review